Literatur
Fava GA (2007) Financial conflicts of interest in psychiatry. World Psychiatry 6: 19–24
Helmchen H (2003) Psychiater und pharmazeutische Industrie. Nervenarzt 74: 953–964
Henderson C, Howard L, Wilkinson G (2003) Acknowledgement of psychiatric research funding. Br J Psychiatry 183: 273–5: 273–275
Horton R (1997) Conflicts of interest in clinical research: opprobrium or obsession? Lancet %19;349: 1112–1113
Komesaroff PA, Kerridge IH (2002) Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry. Med J Aust 176: 118–121
Miller FG, Pickar D, Rosenstein DL (1999) Addressing ethical issues in the psychiatric research literature. Arch Gen Psychiatry 56: 763–764
Möller HJ (2005) Are placebo-controlled studies required in order to prove efficacy of antidepressants? World J Biol Psychiatry 6: 130–131
Möller HJ (2006) Ethical aspects of publishing. World J Biol Psychiatry 7: 66–69
Möller HJ (2007) Do effectiveness studies tell us the real truth? World J Biol Psychiatry 8: 138–140
Möller HJ, Fritze J (2008) (Irrationale) Rationisierung von Psychopharmaka im deutschen Gesundheitssystem. Zur Problematik von „Me-too“-Listen. Psychopharmakotherapie 15: 30–35
Möller HJ, Maier W (2007) Probleme der „evidence-based medicine“ in der Psychopharmakotherapie. Problematik der Evidenzgraduierung und der Evidenzbasierung komplexer klinischer Entscheidungsprozesse. Nervenarzt 78: 1014–1027
Rothman KJ (1993) Conflict of interest. The new McCarthyism in science. JAMA 269: 2782–2784
Stossel TP (2008) Has the hunt for conflicts of interest gone too far? Yes. BMJ 336: 476
The royal australasian college of physicians guidelines for ethical relationships between physicians and industry. (2006) http://www. racp. edu. au/page/publications-and-communications. 3rd.Anonymous
Interessenkonflikt
Der korrespondierende Autor weist auf folgende Beziehungen hin: Professor Möller hat von den folgenden Firmen Forschungsgelder erhalten bzw. er ist Mitglied des Advisory Boards oder erhält Honorare für Vorträge: AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Eisai, GlaxoSmithKline, Janssen-Cilag, Lundbeck, Merck, Novartis, Organon, Pfizer, Sanofi Aventis, Sepracor, Servier, Wyeth.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Möller, HJ. Deklaration von Interessenkonflikten bei wissenschaftlichen Publikationen. Nervenarzt 79, 1001–1005 (2008). https://doi.org/10.1007/s00115-008-2543-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00115-008-2543-x